C07K

Peptides & Proteins (Biologics)

USPTO Patent Applications

← All categories

119 items

Application

Method And Reagents For Ultrasensitive Immunoassay

US20260079158A1 · Mar 19, 2026
G01N C07K
Application

Pathogen Surrogates Based On Encapsulated Tagged Dna For Verification Of Sanitation And Wash Water Systems For Fresh Produce

US20260079142A1 · Mar 19, 2026
G01N A61L
Application

Tau Phospho (Thr217) Binding Antibodies And Antigen Binding Fragments Thereof

US20260079168A1 · Mar 19, 2026
G01N C07K
Application

Multivalent Chlorotoxin Chimeric Antigen Receptors

US20260078529A1 · Mar 19, 2026
C40B A61K
Application

Orthogonal Mutations For Heterodimerization

US20260078202A1 · Mar 19, 2026
C07K A61K
Application

Anti Ptk7 Antibody, And Use Thereof

US20260078201A1 · Mar 19, 2026
C07K A61P
Application

Systems And Methods For Targeting Cancer Cells

US20260078200A1 · Mar 19, 2026
C07K A61K
Application

Methods And Materials For Assessing Response To Plasmablast And Plasma Cell Depleting Therapies

US20260078199A1 · Mar 19, 2026
C07K A61P
Application

Methods For Treating Cancer Using Subcutaneous Dosing Of Mosunetuzumab In Combination With Polatuzumab Vedotin

US20260078198A1 · Mar 19, 2026
C07K A61K
Application

Genetically Modified Non Human Animals And Methods For Producing Heavy Chain Antibodies

US20260078197A1 · Mar 19, 2026
C07K A01K
Application

Multispecific Constructs And Uses Thereof

US20260078196A1 · Mar 19, 2026
C07K A61P
Application

Multi Specific Antibody Binding To Bcma, Gprc5 D And Cd3, And Use Thereof

US20260078195A1 · Mar 19, 2026
C07K A61P
Application

Anti Tl1 A Antibody Therapeutic Methods

US20260078194A1 · Mar 19, 2026
C07K A61K
Application

Therapeutic Agents For Ocular Inflammatory Disease Comprising Interleukin 6 Receptor Inhibitor As Active Ingredient

US20260078193A1 · OSAKA UNIVERSITY · Mar 19, 2026
C07K A61K
Application

Treatment For Sleep Loss Or Sleep Disturbance In Patients With Dermatitis

US20260078192A1 · Mar 19, 2026
C07K A61P
Application

Combination Therapies With Bispecific Anti Egfr/C Met Antibodies And 3 Rd Generation Egfr Tyrosine Kinase Inhibitors

US20260078191A1 · Mar 19, 2026
C07K A61K
Application

Bispecific Tetravalent Antibodies And Methods Of Making And Using Thereof

US20260078190A1 · SystImmune, Inc. · Mar 19, 2026
C07K A61K
Application

Methods Of Treating Chronic Inflammatory Demyelinating Polyneuropathy Using Anti Fcrn Antibodies

US20260078189A1 · Immunovant Sciences GmbH · Mar 19, 2026
C07K A61K
Application

Methods Of Treating Graves’ Disease Using Anti Fcrn Antibodies

US20260078188A1 · Immunovant Sciences GmbH · Mar 19, 2026
C07K C07K
Application

Methods Of Treating Cancer With An Anti Pd L1 Antibody

US20260078187A1 · Mar 19, 2026
C07K A61K
Application

Anti Pdl1 Antibody And Use Thereof

US20260078186A1 · Mar 19, 2026
C07K A61P
Application

Anti Vista Constructs And Uses Thereof

US20260078185A1 · Mar 19, 2026
C07K A61P
Application

Lag 3 Combination Therapy For The Treatment Of Cancer

US20260078184A1 · Bristol-Myers Squibb Company · Mar 19, 2026
C07K A61K
Application

Treating Chronic Inflammation And Cancer By Macrophage Polarization

US20260078183A1 · Mar 19, 2026
C07K A61K
Application

Therapeutic Agent For T Cell Malignancies

US20260078182A1 · MEIJI SEIKA PHARMA CO., LTD. · Mar 19, 2026
C07K A61K
Application

Trem 2 Agonists For The Treatment Of Marfan Syndrome

US20260078181A1 · Mar 19, 2026
C07K C07K
Application

Anti Par2 Antibodies And Uses Thereof

US20260078180A1 · Mar 19, 2026
C07K A61P
Application

Cdh17 Antibodies And Uses Thereof

US20260078179A1 · Mar 19, 2026
C07K A61K
Application

Methods And Compositions For Increasing Iduronate 2 Sulfatase Activity In The Cns

US20260078178A1 · Mar 19, 2026
C07K C07K
Application

Connexin (Cx)43 Hemichannel Binding Antibodies And Uses Thereof

US20260078177A1 · Mar 19, 2026
C07K A61K
Application

Anti Abeta Antibodies

US20260078176A1 · Mar 19, 2026
C07K C07K
Application

Anti Sema3 A Antibodies And Their Uses For Treating A Thrombotic Disease Of The Retina

US20260078175A1 · Mar 19, 2026
C07K A61P
Application

Single Chain Medi1341 Antibody Transferrin Fusion Protein For Enhanced Efficacy And Indications

US20260078174A1 · Mar 19, 2026
C07K C07K
Application

Single Chain Zagotenemab Antibody Transferrin Fusion Protein For Enhanced Efficacy And Indications

US20260078173A1 · Mar 19, 2026
C07K C07K
Application

Hcv Antigens And Antibodies

US20260078172A1 · Mar 19, 2026
C07K A61K
Application

Sars Cov2 Antibodies And Uses Thereof

US20260078171A1 · Mar 19, 2026
C07K A61P
Application

Pan Neutralizing Sars Co V 2 M Ab Composition And Methods Of Treatment Thereof

US20260078170A1 · Washington University · Mar 19, 2026
C07K A61K
Application

Hepatitis B Antibodies

US20260078169A1 · Mar 19, 2026
C07K A61K
Application

Non Animal Based Protein Sources With Functional Properties

US20260078168A1 · Clara Foods Co. · Mar 19, 2026
C07K A21D
Application

Fusion Protein

US20260078167A1 · Mar 19, 2026
C07K A61P
Application

Anti Dll3 Chimeric Antigen Receptors And Uses Thereof

US20260078166A1 · Mar 19, 2026
C07K A61K
Application

Processes For Generating Engineered Cells And Compositions Thereof

US20260078165A1 · Juno Therapeutics, Inc. · Mar 19, 2026
C07K A61K
Application

Fusion Protein Capable Of Self Assembly By Comprising Purification Tag And A Helix Tag, And Method For Purifying Recombinant Protein By Using Same

US20260078426A1 · Mar 19, 2026
C12P C07K
Application

Materials And Methods For Treatment Of Pain Related Disorders

US20260078414A1 · Vertex Pharmaceuticals Incorporated · Mar 19, 2026
C12N A61K
Application

Methods And Products For Expressing Proteins In Cells

US20260078413A1 · Mar 19, 2026
C12N A61K
Application

Novel Genomic Safe Harbor And Use Thereof

US20260078411A1 · Mar 19, 2026
C12N C07K
Application

Compositions And Methods For Selective Gene Regulation

US20260078404A1 · Mar 19, 2026
C12N A61P
Application

Zikv Based Gene Delivery System

US20260078403A1 · Mar 19, 2026
C12N A61K
Application

Circular Rna For Translation In Eukaryotic Cells

US20260078400A1 · Mar 19, 2026
C12N C07K
Application

Use Of Glycine Soja Zinc Finger Protein 4 (Gs Zfp4) Or Genetic Material Thereof

US20260078399A1 · Mar 19, 2026
C12N C07K
Application

Plants Genetically Engineered For Increased Water Use Efficiency And Carbon Intake And Methods For Making And Using Them

US20260078398A1 · Mar 19, 2026
C12N C07K
Application

Compositions And Methods For Protein Production

US20260078395A1 · Mar 19, 2026
C12N C07K
Application

Thph2 Protein From Trichoderma Harzianum, Zm Glp1 17 Protein From Zea Mays L., And Method For Preparing Transgenic Zea Mays L.

US20260078390A1 · SHANGHAI JIAO TONG UNIVERSITY · Mar 19, 2026
C12N A01N
Application

Method For Efficient Genetic Transformation And Gene Editing Of Brassica Crop Mediated By Agrobacterium Rhizogenes

US20260078389A1 · Mar 19, 2026
C12N C07K
Application

Insect Resistant Inir6 Transgenic Maize Plants Lacking A Selectable Marker And Junction

US20260078388A1 · Mar 19, 2026
C12N A01H
Application

Genetically Modified Microorganism, Method(s) And Application(s) Thereof

US20260078386A1 · Mar 19, 2026
C12N C07K
Application

Trans Splicing Molecules

US20260078380A1 · Mar 19, 2026
C12N C07K
Application

Compounds And Compositions For Intracellular Delivery Of Therapeutic Agents

US20260078082A1 · Mar 19, 2026
C07C A61K
Application

Food Protein And Starch Purification And Water Recycling Methods

US20260078026A1 · Mar 19, 2026
C02F A23J
Application

Regulatable Cell Surface Receptors And Related Compositions And Methods

US20260078164A1 · Mar 19, 2026
C07K A61K
Application

T Cell Receptor That Targets Egfr Mutation And Methods Of Using The Same

US20260078163A1 · Mar 19, 2026
C07K A61K
Application

Reversible Control Of Chimeric Antigen Receptor T Cells

US20260078162A1 · Mar 19, 2026
C07K C07K
Application

Methods Of Using Activin Receptor Type Ii Variants

US20260078161A1 · Mar 19, 2026
C07K A61K
Application

Lag 3 Targeted Heterodimeric Fusion Proteins Containing Il 15/Il 15 Ra Fc Fusion Proteins And Lag 3 Antigen Binding Domains

US20260078160A1 · Mar 19, 2026
C07K C07K
Application

Novel Pd1 Targeted Il 15 Immunocytokine And Vitokine Fusions

US20260078159A1 · Mar 19, 2026
C07K A61P
Application

Compositions Comprising Cxcl10 Derived Peptides And Methods Of Use Thereof

US20260078158A1 · University of Virginia Patent Foundation · Mar 19, 2026
C07K A01N
Application

Fgf21 Mutant Polypeptides

US20260078157A1 · Mar 19, 2026
C07K C07K
Application

Treatment Of Nervous System Injury And Neurodegenerative Disorders And Related Conditions

US20260078156A1 · Mar 19, 2026
C07K A61K
Application

Novel Folr1 Specific Binding Proteins For Cancer Diagnosis And Treatment

US20260078155A1 · Mar 19, 2026
C07K A61K
Application

System And Method For Redirecting Audio And Video Data Streams In A Display Server Computing System

US20260078154A1 · Netzyn, Inc. · Mar 19, 2026
C07K A61P
Application

Modified Cry1 Ca Toxins Useful For Control Of Insect Pests

US20260078153A1 · CORTEVA AGRISCIENCE LLC · Mar 19, 2026
C07K A01N
Application

Enzymatically Active Domains From Anti Staphylococcal Phage Proteins

US20260078152A1 · Mar 19, 2026
C07K A61K
Application

Novel Polypeptide

US20260078151A1 · Mar 19, 2026
C07K A61K
Application

Mutated Glycoprotein Of Vesicular Stomatitis Virus

US20260078150A1 · Mar 19, 2026
C07K C12N
Application

Compositions And Methods For The Treatment Of Metabolic And Liver Disorders

US20260078149A1 · Mar 19, 2026
C07K A61P
Application

Amatoxin Antibody Drug Conjugates And Uses Thereof

US20260078148A1 · Heidelberg Pharma Research GmbH · Mar 19, 2026
C07K A61K
Application

Inhibitors For Protein N Terminal Methyltransferase And Uses Thereof

US20260078147A1 · Mar 19, 2026
C07K C07K
Application

Epha2 Targeting Agents And Uses Thereof

US20260078146A1 · The Regents of the University of California · Mar 19, 2026
C07K A61K
Application

Polypeptides Having Cholesterol Lowering Function In Soybean Protein Hydrolysate, Preparation Method Thereof, And Uses Thereof

US20260078145A1 · Mar 19, 2026
C07K A61P
Application

Active Peptide, And Composition And Use Thereof

US20260078144A1 · Mar 19, 2026
C07K A61K
Application

Compositions And Methods For Trehalose Phospholipids

US20260078140A1 · Mar 19, 2026
C07H A61K
Application

Dna Polymerase Based Genome Editing System And Method

US20260078361A1 · Mar 19, 2026
C12N C12N
Application

Engineered Proteins And Methods Of Use Thereof

US20260078360A1 · Mar 19, 2026
C12N C07K
Application

Rna Programmable Epigenetic Rna Modifiers And Uses Thereof

US20260078355A1 · The Broad Institute, Inc. · Mar 19, 2026
C12N C12N
Application

Enhanced Adoptive Cell Therapy

US20260078349A1 · Mar 19, 2026
C12N A61K
Application

Modified Nk 92 Ha Nk003 Cells For The Clinic

US20260078342A1 · Mar 19, 2026
C12N A61K
Application

Treatment Of Cancer Using Chimeric Antigen Receptor

US20260078341A1 · Mar 19, 2026
C12N A61K
Application

E. Coli Strains Having An Oxidative Cytoplasm

US20260078337A1 · Mar 19, 2026
C12N C07K
Application

Targeted Delivery Of Theranostic Agents

US20260077071A1 · Mar 19, 2026
A61K C07B
Application

Atp Independent Bioluminescent Reporter Variants To Improve In Vivo Imaging

US20260077068A1 · Mar 19, 2026
A61K C07D
Application

Antibody Gene Therapy For Treatment And Prevention Of Infection By Rabies Lyssavirus

US20260077062A1 · Auburn University · Mar 19, 2026
A61K A61P
Application

Compositions And Methods For In Vivo Nuclease Mediated Gene Targeting For The Treatment Of Genetic Disorders In Adult Patients

US20260077061A1 · The Trustees of the University of Pennsylvania · Mar 19, 2026
A61K A61K
Application

Anti Ghrelin Butyrylcholinesterase Enzyme Therapeutic

US20260077059A1 · Mar 19, 2026
A61K A61K
Application

Linker Payload Compound, Conjugates And Applications Thereof

US20260077056A1 · Mar 19, 2026
A61K A61K
Application

Compositions Of Polyplexes And Saponins

US20260077055A1 · Mar 19, 2026
A61K A61K
Application

Combinations Of Anti Gip Antibodies And Incretins And Uses Thereof

US20260077054A1 · Mar 19, 2026
A61K A61K
Application

Method To Generate Improving Car T Cells

US20260077045A1 · Mar 19, 2026
A61K A61K
Application

Methods Of Treating Psoriatic Arthritis Using Il 17 Antagonists

US20260077042A1 · Mar 19, 2026
A61K A61K
Application

Bispecific Fusion Protein Targeting Tnf A And Il 17 A, And Use Thereof

US20260077041A1 · Mar 19, 2026
A61K A61K
Application

Anti Human Complement C5 Antibody And Fusion Protein Thereof

US20260077039A1 · Mar 19, 2026
A61K A61K
Application

Immunization Method Against Infection By Sars Co V 2

US20260077035A1 · Imam Abdulrahman Bin Faisal University · Mar 19, 2026
A61K A61K
Application

Multivalent Carriers And Related Vaccine Compositions

US20260077034A1 · Mar 19, 2026
A61K A61K
Application

Kari Nanoparticle

US20260077032A1 · La Jolla Institute for Immunology · Mar 19, 2026
A61K A61K
Application

Nucleic Acids Encoding Human Endogenous Retrovirus K (Herv K) Envelope Proteins Containing Modified Immunosuppressive Domains (Isd) And Uses Thereof

US20260077031A1 · INPROTHER APS · Mar 19, 2026
A61K A61K
Application

Membrane Vesicles Comprising Multiple Influenza Antigens For Vaccines

US20260077030A1 · Mar 19, 2026
A61K A61P
Application

Methods For Treating Netosis And Neutrophil Activation

US20260077028A1 · TRUSTEES OF BOSTON UNIVERSITY · Mar 19, 2026
A61K A61K
Application

Peptide And Nucleic Acid Methods To Modulate Delivery Of Nucleic Acid Structures, Polypeptides, And Their Cargoes

US20260077027A1 · Mar 19, 2026
A61K A61P
Application

Novel Composition Comprising Antibodies

US20260077016A1 · Mar 19, 2026
A61K A61K
Application

Cellular Immunotherapy Compositions And Uses Thereof

US20260077015A1 · Mar 19, 2026
A61K A61K
Application

Oncolytic Virus Expressing An Immune Cell Engager For Tumor Targeting

US20260077006A1 · Mar 19, 2026
A61K A61P
Application

Compositions And Methods For Treatment Of Cardiac Disorders

US20260077004A1 · University of Massachusetts · Mar 19, 2026
A61K A61K
Application

Bacterial Compositions And Methods Of Use

US20260077001A1 · Mar 19, 2026
A61K A61K
Application

Metabolic Modulation Of Intratumoral Cholesterol With Engineered Bacteria For The Treatment Of Cancers

US20260077000A1 · Mar 19, 2026
A61K A61K
Application

Bispecific Chimeric Antigen Receptors Targeting Cd20 And Bcma

US20260076995A1 · ABELZETA INC. · Mar 19, 2026
A61K A61K
Application

Gastrin Releasing Peptide Receptor (Grpr) Targeted Compounds And Uses Thereof

US20260077073A1 · Mar 19, 2026
A61K A61K
Application

Virus Like Particles For Preventing The Spreading And Lowering The Infection Rate Of Viruses

US20260076920A1 · Mar 19, 2026
A61K A61K
Application

Particles, Method For Producing Particles, And Pharmaceutical Composition

US20260076911A1 · ETRIA Co., Ltd. · Mar 19, 2026
A61K A61K
Application

Formulations Of Anti Interleukin 1 Receptor 1 Antibodies

US20260076903A1 · Mar 19, 2026
A61K A61K
Application

Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain I

US20260076347A1 · Mar 19, 2026
A01K C07K